MX2010010416A - Formulaciones liquidas y secadas por congelamiento. - Google Patents

Formulaciones liquidas y secadas por congelamiento.

Info

Publication number
MX2010010416A
MX2010010416A MX2010010416A MX2010010416A MX2010010416A MX 2010010416 A MX2010010416 A MX 2010010416A MX 2010010416 A MX2010010416 A MX 2010010416A MX 2010010416 A MX2010010416 A MX 2010010416A MX 2010010416 A MX2010010416 A MX 2010010416A
Authority
MX
Mexico
Prior art keywords
liquid
freeze dried
formulations
dried formulations
compounds
Prior art date
Application number
MX2010010416A
Other languages
English (en)
Inventor
Didier Nourrisson
Nathalie Mondoly
Naziha Benamar
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MX2010010416A publication Critical patent/MX2010010416A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a formulaciones parenterales estables que comprenden una nueva clase de compuestos, que son un compuesto no proteínico, a un método para la preparación de tales formulaciones así como al uso de ciertos compuestos para la estabilización de estas formulaciones.
MX2010010416A 2008-04-04 2009-04-03 Formulaciones liquidas y secadas por congelamiento. MX2010010416A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08290330A EP2106788A1 (en) 2008-04-04 2008-04-04 Liquid and freeze dried formulations
PCT/IB2009/005441 WO2009122288A2 (en) 2008-04-04 2009-04-03 Liquid and freeze dried formulations

Publications (1)

Publication Number Publication Date
MX2010010416A true MX2010010416A (es) 2010-10-08

Family

ID=39616574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010416A MX2010010416A (es) 2008-04-04 2009-04-03 Formulaciones liquidas y secadas por congelamiento.

Country Status (9)

Country Link
US (1) US20110034399A1 (es)
EP (2) EP2106788A1 (es)
JP (1) JP2011516461A (es)
CN (1) CN101980699A (es)
BR (1) BRPI0910245A2 (es)
CA (1) CA2720183A1 (es)
EA (1) EA026064B1 (es)
MX (1) MX2010010416A (es)
WO (1) WO2009122288A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150116468A (ko) 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
WO2021067897A1 (en) * 2019-10-04 2021-04-08 Tiburio Therapeutics Inc. Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
JPH1038883A (ja) * 1996-07-24 1998-02-13 Eiken Chem Co Ltd 抗原活性の安定化方法
TR200002543T2 (tr) * 1998-03-03 2000-11-21 Shionogi & Co., Ltd. Fosfolipaz önleyici sodyum [[3-(2-amino-1,2-dioksietil-1-fenilmetil) -2-etil-1-fenilmetil)- 1H-indol-4-il]oksi] asetat içeren farmasötik kompozisyonlar
FR2791895B1 (fr) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
US20080096858A1 (en) * 2004-04-22 2008-04-24 University Of Connecticut Method of Stabilizing Disordered Cefovecin Sodium Salt
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
EP2389930A1 (en) * 2006-03-31 2011-11-30 Erasmus University Medical Center Rotterdam Novel composition for tumor growth control

Also Published As

Publication number Publication date
WO2009122288A2 (en) 2009-10-08
WO2009122288A3 (en) 2009-12-03
US20110034399A1 (en) 2011-02-10
CN101980699A (zh) 2011-02-23
EA201071164A1 (ru) 2011-04-29
EP2280693A2 (en) 2011-02-09
CA2720183A1 (en) 2009-10-08
EA026064B1 (ru) 2017-02-28
BRPI0910245A2 (pt) 2015-09-29
EP2106788A1 (en) 2009-10-07
JP2011516461A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2010063700A3 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
MX2013006926A (es) Compuestos y composiciones fotocromicas.
MY153915A (en) Organic compounds
MX2010007952A (es) Arilpirrolinas insecticidas.
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
WO2011141110A3 (de) Photostabilisatoren
MY150778A (en) Fused heterocyclic compound
WO2008113559A3 (en) Indolizines and aza-analog derivatives thereof as cns active compounds
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
WO2009127718A3 (en) Novel microbiocides
MX2010006787A (es) Análogos halogenados de agentes anti-fibroticos.
TN2011000355A1 (en) Novel microbiocides
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2010010416A (es) Formulaciones liquidas y secadas por congelamiento.
WO2012078544A3 (en) Benzylidene substituted 2,4-pentanedione compounds and use thereof as stabilizers
MX342311B (es) Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl).
IN2012DN01223A (es)
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
DK1957463T3 (da) Fremgangsmåde til fremstilling af 5-fluor-1,3-dialkyl-1H-pyrazol-4-carboxylsyrechlorider
MX344429B (es) Nuevos compuestos de hexahidropirroloimidazolona.
WO2011031764A3 (en) Compounds and related methods of use
WO2013175498A3 (en) Amido-amine and glycerol based compound and process of preparation
IN2015DN02648A (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal